IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California

Pharmaceutical

IDEAYA Biosciences

IDEAYA Biosciences' headquarters in South San Francisco, CA, United States

Yujiro S. Hata

Stu Dorman

Francine Zelaya

Senior Vice President, Chief General Counsel

Daniel Simon

Andres Ruiz Briseno

Claire L. Neilan

Jasgit Sachdev

Paul A. Barsanti

Michael White

Darrin M. Beaupre

Mick O’Quigley

Scott Morrison

Bill Sellers

Jeffrey Stein

Wendy Yarno

Elizabeth Swisher

Terry Rosen

Trey Ideker

Frank McCormick

Garret Hampton

Susan L. Kelley

Alan D. D’Andrea

Karlene Cimprich

Kornelia Polyak

Director/senior Director, DMPK And Clinical Pharmacology

Senior Medical Director, Patient Safety & Pharmacovigilance

Payroll Manager

Director, Safety Science

Associate Director/director, Head Of Discovery Analytical Chemistry

Senior Clinical Data Manager, Data Management

Medical Director (early Development)

Description

People (14)

Terry Rosen

Claire L. Neilan

Arjun Arkal Rao

Aaron Albers

Peter Teriete

Kelly Trego

Nour Ghaddar

Daniel Simon

George Cole Jr.

Francine Zelaya

Melissa Fleury

Monica V.

Talat A.

Erin Chui

Jobs (8)